Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
NBC Pitches Ad Buyers Amid Writers' Strike
Cheddar News attended the upfront presentation by NBC Universal and broke down how this year's event was different from previous years due to the ongoing writers' strike.
Load More